1.02 USD
▼+0.04-2.86%
盘后 1.04 -0.94%
2026-08-03
市值
$2.32M
市盈率
—
EPS
-32.41
股息率
—
52 周区间
0.95 – 268.00
成交量
47.64K
Beta
3.27
目标价
—
52W 低 0.9552W 高 268.00
价格走势
公司简介
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the Un...